Hundreds of thousand of people could die in a nuclear attack, but hundreds of thousands of others could be saved. That’s because the Pentagon — after decades of searching — believes it has found a drug to treat radiation exposure. Why isn’t that drug available? Because bureaucratic red tape is blocking the availability of Neumune, a drug developed by San Diego biotech firm Hollis Eden to treat Acute Radiation Syndrome — via Boing Boing
Share this Story